Table 3 Comparison of baseline characteristics between the patients with anterior model LA-CV ≥ 0.80 m/s and those with LA-CV < 0.80 m/s
Parameters | Anterior model LA-CV ≥ 0.80 m/s N = 69 | Anterior model LA-CV < 0.80 m/s N = 50 | P-value |
|---|---|---|---|
Age (years) | 67.6 ± 9.4 | 69.0 ± 7.1 | 0.370 |
Gender (male/female, %) | 48/21 (69.6) | 27/23 (54.0) | 0.083 |
Body mass index (kg/m2) | 23.8 ± 4.8 | 22.8 ± 5.7 | 0.299 |
Current or former smoker (%) | 30 (55.6) | 15 (53.6) | 0.864 |
Persistent AF (%) | 27 (39.1) | 35 (70.0) | 0.001 |
Comorbidity | Â | Â | Â |
Type 2 diabetes mellitus (%) | 8 (11.6) | 12 (24.0) | 0.074 |
Hypertension (%) | 40 (58.0) | 26 (52.0) | 0.518 |
Dyslipidemia (%) | 21 (30.4) | 18 (36.0) | 0.523 |
Chronic kidney disease (%) | 26 (37.7) | 17 (34.0) | 0.680 |
Coronary artery disease (%) | 4 (5.8) | 6 (12.0) | 0.318 |
Congestive heart failure (%) | 17 (24.6) | 15 (30.6) | 0.472 |
Previous stroke (%) | 8 (11.6) | 11 (22.0) | 0.126 |
CHADS2 score | 1.4 ± 1.0 | 1.8 ± 1.3 | 0.161 |
CHA2DS2-VASc score | 2.5 ± 1.5 | 3.1 ± 1.6 | 0.036 |
Medication at admission (%) | Â | Â | Â |
ACE inhibitor or ARB (%) | 32 (46.4) | 26 (52.0) | 0.545 |
Beta-blocker (%) | 38 (55.1) | 24 (48.0) | 0.446 |
Echocardiography | Â | Â | Â |
LA dimension (mm) | 40.3 ± 6.5 | 41.2 ± 6.1 | 0.419 |
LV ejection fraction (%) | 65.1 ± 13.3 | 64.5 ± 13.2 | 0.788 |
E/e’ | 12.1 ± 4.8 | 13.0 ± 4.4 | 0.324 |
LAA emptying velocity (m/s) | 49.1 ± 21.1 | 42.5 ± 20.4 | 0.109 |
Primary measurements | Â | Â | Â |
Anterior LA-LVA (cm2) | 9.2 ± 7.3 | 14.5 ± 10.5 | 0.003 |
Posterior LA-LVA (cm2) | 5.4 ± 4.3 | 7.2 ± 6.8 | 0.093 |